KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Xenon Pharmaceuticals (XENE) Operating Margin (2016 - 2025)

Historic Operating Margin for Xenon Pharmaceuticals (XENE) over the last 11 years, with Q1 2025 value amounting to 969.84%.

  • Xenon Pharmaceuticals' Operating Margin changed N/A to 969.84% in Q1 2025 from the same period last year, while for Sep 2025 it was 4543.73%, marking a year-over-year change of. This contributed to the annual value of 1368.91% for FY2022, which is 9404600.0% down from last year.
  • According to the latest figures from Q1 2025, Xenon Pharmaceuticals' Operating Margin is 969.84%.
  • Xenon Pharmaceuticals' Operating Margin's 5-year high stood at 198.14% during Q1 2022, with a 5-year trough of 28884.85% in Q3 2022.
  • Moreover, its 3-year median value for Operating Margin was 817.25% (2021), whereas its average is 4762.84%.
  • The largest annual percentage gain for Xenon Pharmaceuticals' Operating Margin in the last 5 years was 1703500bps (2022), contrasted with its biggest fall of -285382300bps (2022).
  • Xenon Pharmaceuticals' Operating Margin (Quarter) stood at 664.65% in 2021, then crashed by -4246bps to 28884.85% in 2022, then soared by 97bps to 969.84% in 2025.
  • Its last three reported values are 969.84% in Q1 2025, 28884.85% for Q3 2022, and 5655.78% during Q2 2022.